The rare variant TP53 3’UTR rs78378222 (A>C) studied here was initially reported as a risk allele for diverse tumor types in European and North American populations (Stacey et al., 2011; Egan et al., 2012; Zhou et al., 2012; Enciso-Mora et al., 2013; Diskin et al. 2014; Wang et al. 2015). This evidence concerns the gene TP53 and neoplasm.